B-Cell Depletion Therapy Market Competitive Landscape Driven by Biologic Drug Innovation
NEWARK, Del. — The global B-Cell Depletion Therapy Market is projected to increase from USD 26.7 billion in 2026 to USD 62.6 billion by 2036, expanding at a CAGR of 8.9% during 2026–2036, according to Future Market Insights. Market expansion is being supported by the rising prevalence of autoimmune and hematologic conditions, broader adoption of next-generation B-cell therapies,...
0 Comentários 0 Compartilhamentos 3 Visualizações 0 Anterior